Company: SHPH
Filing Date: 2025-02-27
Form Type: 424B3
Source: 0001493152-25-008474
Chunk: 152

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-27
Form: 424B3
Chunk 152
---
2018 Equity Incentive Plan

Our 2018 Equity Incentive Plan (the “Plan”) provides for equity incentives to be granted to our employees, executive officers or directors and to key advisers and consultants. Equity incentives may be in the form of stock options with an exercise price of not less than the fair market value of the underlying shares as determined pursuant to the Plan, restricted stock awards, other stock- based awards, or any combination of the foregoing. The Plan is administered by the Company’s compensation committee or, alternatively, if there is no compensation committee, the Company’s board of directors. We have reserved 3,000,000 shares of our common stock for issuance under the Plan, of which 1,187,189 shares have been granted under the Plan as of the date of this Annual Report, of which 1,084,644 remain subject to vesting.

The following table provides information as of December 31, 2024 about our equity compensation plans and arrangements.

| Plan category                                              |     | Number of securities to be issued upon exercise of outstanding options, warrants and rights |           |     | Weighted- average exercise price of outstanding options, warrants and rights |      |     | Number of securities remaining available for future issuance under equity compensation plans |           |
|:-----------------------------------------------------------|:----|:--------------------------------------------------------------------------------------------|----------:|:----|:-----------------------------------------------------------------------------|-----:|:----|:---------------------------------------------------------------------------------------------|----------:|
| Equity compensation plans approved by security holders     |     |                                                                                             | 1,084,644 |     | $                                                                            | 0.84 |     |                                                                                              | 1,231,910 |
| Equity compensation plans not approved by security holders |     |                                                                                             |         – |     |                                                                              |    – |     |                                                                                              |         – |
| Total                                                      |     |                                                                                             | 1,084,644 |     |                                                                              | 0.84 |     |                                                                                              | 1,231,910 |

*Outstanding equity incentive grants consist entirely of restricted stock units which automatically vest over time into an equal number of shares of common stock at no additional cost to the holder.

You may find additional information regarding our equity compensation plans in Note 6 of the Notes to our Consolidated Financial Statements.

Item 13. Certain Relationships and Related Transactions, and Director Independence

Related Party Transactions

Unless described below, during the last two fiscal years, there were no transactions or series of similar transactions to which we were a